Cite
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.
MLA
Weichselbaum RR, et al. “Radiation-Induced Tumour Necrosis Factor-Alpha Expression: Clinical Application of Transcriptional and Physical Targeting of Gene Therapy.” Lancet Oncology, vol. 3, no. 11, Nov. 2002, pp. 665–71. EBSCOhost, https://doi.org/10.1016/s1470-2045(02)00900-2.
APA
Weichselbaum RR, Kufe DW, Hellman S, Rasmussen HS, King CR, Fischer PH, Mauceri HJ, Weichselbaum, R. R., Kufe, D. W., Hellman, S., Rasmussen, H. S., King, C. R., Fischer, P. H., & Mauceri, H. J. (2002). Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy. Lancet Oncology, 3(11), 665–671. https://doi.org/10.1016/s1470-2045(02)00900-2
Chicago
Weichselbaum RR, Kufe DW, Hellman S, Rasmussen HS, King CR, Fischer PH, Mauceri HJ, et al. 2002. “Radiation-Induced Tumour Necrosis Factor-Alpha Expression: Clinical Application of Transcriptional and Physical Targeting of Gene Therapy.” Lancet Oncology 3 (11): 665–71. doi:10.1016/s1470-2045(02)00900-2.